Coverage
Health Care Technology
Equity Research
Solventum Corp. (SOLV)
SELL. 12-month probability-weighted target $76 (-13% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.
Equity Research
Doximity Inc (DOCS)
SELL. 12-month probability-weighted target $21 (-31% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.
Equity Research
Veeva Systems Inc Class A (VEEV)
SELL. 12-month probability-weighted target $157 (-47% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.